Home
About
Overview
Sharing Data
ORCID
Help
History (1)
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. JCI Insight. 2018 07 26; 3(14).
View in:
PubMed
subject areas
Adipose Tissue
Adipose Tissue
Animals
Animals
Breast Neoplasms
Breast Neoplasms
Diet
Diet
Disease Progression
Disease Progression
Estrogens
Estrogens
Female
Female
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Homeodomain Proteins
Homeodomain Proteins
Humans
Humans
Loss of Function Mutation
Loss of Function Mutation
Mice
Mice
Obesity
Obesity
Receptor, Fibroblast Growth Factor, Type 1
Receptor, Fibroblast Growth Factor, Type 1
Receptors, Estrogen
Receptors, Estrogen
Signal Transduction
Signal Transduction
Tamoxifen
Tamoxifen
Tumor Microenvironment
Tumor Microenvironment
Weight Gain
Weight Gain
authors with profiles
Elizabeth A Wellberg
Michael Carleton Rudolph